Fibronectin attachment protein from bacillus Calmette-Guerin as targeting agent for bladder tumor cells

International Journal of Cancer

Volumn 131, Issue 3, 2012, Pages 591-600

  Coon, Brian G ^a,b,e   Crist, Scott ^b,c   González Bonet, Andrés M ^b,d   Kim, Hee Kwon ^b,d   Sowa, Jennifer ^b,c   Thompson, David H ^b,d   Ratliff, Timothy L ^b,c   Aguilar, R Claudio ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b Purdue University   (United States)

^c PURDUE UNIVERSITY   (United States)

^d PURDUE UNIVERSITY   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bacillus Calmette Guerin; bladder cancer; caveolae; fibronectin attachment protein; integrins

Indexed keywords

BCG VACCINE; CLATHRIN; FIBRONECTIN; FIBRONECTIN BINDING PROTEIN; INTEGRIN; LIPOSOME; NITRILOTRIACETATE NICKEL; POLYCLONAL ANTIBODY;

ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CAVEOLA; CELL ADHESION; CELL MEMBRANE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFICACY; DRUG TARGETING; ENDOCYTOSIS; ENDOSOME; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERNALIZATION; INTRACELLULAR TRANSPORT; LYSOSOME; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN TRANSPORT;

ADMINISTRATION, INTRAVESICAL; CAVEOLIN 1; CELL LINE, TUMOR; CLATHRIN; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; FIBRONECTINS; HUMANS; INTEGRINS; LIPOSOMES; LYSOSOMES; MYCOBACTERIUM BOVIS; OLIGOPEPTIDES; PROTEIN TRANSPORT; URINARY BLADDER NEOPLASMS;

EID: 84861577057     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26413     Document Type: Article

References (30)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ,. Cancer statistics, 2004. CA Cancer J Clin 2004; 54: 8-29.
2. Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R,. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 2003; 21: 1315-30.
3. Romih R, Korosec P, de Mello W Jr, Jezernik K,. Differentiation of epithelial cells in the urinary tract. Cell Tissue Res 2005; 320: 259-68.
4. Truschel ST, Wang E, Ruiz WG, Leung SM, Rojas R, Lavelle J, Zeidel M, Stoffer D, Apodaca G,. Stretch-regulated exocytosis/endocytosis in bladder umbrella cells. Mol Biol Cell 2002; 13: 830-46.
5. Lilly JD, Parsons CL,. Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg Gynecol Obstet 1990; 171: 493-6.
6. Liang FX, Riedel I, Deng FM, Zhou G, Xu C, Wu XR, Kong XP, Moll R, Sun TT,. Organization of uroplakin subunits: transmembrane topology, pair formation and plaque composition. Biochem J 2001; 355: 13-18.
7. Ratliff TL,. Role of the immune response in BCG for bladder cancer. Eur Urol 1992; 21 (Suppl 2): 17-21.
8. Becich MJ, Carroll S, Ratliff TL,. Internalization of bacille Calmette-Guerin by bladder tumor cells. J Urol 1991; 145: 1316-24.
9. Brandau S, Suttmann H,. Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement. Biomed Pharmacother 2007; 61: 299-305.
10. Lamm DL, McGee WR, Hale K,. Bladder cancer: current optimal intravesical treatment. Urol Nurs 2005; 25: 323-6, 31-2.
11. Ratliff TL, McCarthy R, Telle WB, Brown EJ,. Purification of a mycobacterial adhesin for fibronectin. Infect Immun 1993; 61: 1889-94.
12. Schorey JS, Holsti MA, Ratliff TL, Allen PM, Brown EJ,. Characterization of the fibronectin-attachment protein of Mycobacterium avium reveals a fibronectin-binding motif conserved among mycobacteria. Mol Microbiol 1996; 21: 321-9.
13. Schorey JS, Li Q, McCourt DW, Bong-Mastek M, Clark-Curtiss JE, Ratliff TL, Brown EJ,. A Mycobacterium leprae gene encoding a fibronectin binding protein is used for efficient invasion of epithelial cells and Schwann cells. Infect Immun 1995; 63: 2652-7.
14. Hudson MA, Brown EJ, Ritchey JK, Ratliff TL,. Modulation of fibronectin-mediated bacillus Calmette-Guerin attachment to murine bladder mucosa by drugs influencing the coagulation pathways. Cancer Res 1991; 51: 3726-32.
15. Kavoussi LR, Brown EJ, Ritchey JK, Ratliff TL,. Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response. J Clin Invest 1990; 85: 62-7.
16. Kuroda K, Brown EJ, Telle WB, Russell DG, Ratliff TL,. Characterization of the internalization of bacillus Calmette-Guerin by human bladder tumor cells. J Clin Invest 1993; 91: 69-76.
17. Zhao W, Schorey JS, Groger R, Allen PM, Brown EJ, Ratliff TL,. Characterization of the fibronectin binding motif for a unique mycobacterial fibronectin attachment protein, FAP. J Biol Chem 1999; 274: 4521-6.
18. Sinn HW, Elzey BD, Jensen RJ, Zhao X, Zhao W, Ratliff TL,. The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity. Cancer Immunol Immunother 2008; 57: 573-9.
19. Coon BG, Mukherjee D, Hanna CB, Riese DJ, Lowe M, Aguilar RC,. Lowe syndrome patient fibroblasts display Ocrl1-specific cell migration defects that cannot be rescued by the homologous Inpp5b phosphatase. Hum Mol Genet 2009; 18: 4478-91.
20. Bolte S, Cordelieres FP,. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 2006; 224: 213-32.
21. McGraw TE, Subtil A,. Endocytosis: biochemical analyses. Curr Protoc Cell Biol 2001;Chapter 15:Unit 15 3.
22. Dinneen JL, Ceresa BP,. Expression of dominant negative rab5 in HeLa cells regulates endocytic trafficking distal from the plasma membrane. Exp Cell Res 2004; 294: 509-22.
23. Caswell PT, Vadrevu S, Norman JC,. Integrins: masters and slaves of endocytic transport. Nat Rev Mol Cell Biol 2009; 10: 843-53.
24. Mukherjee S, Ghosh RN, Maxfield FR,. Endocytosis. Physiol Rev 1997; 77: 759-803.
25. Naslavsky N, Rahajeng J, Sharma M, Jovic M, Caplan S,. Interactions between EHD proteins and Rab11-FIP2: a role for EHD3 in early endosomal transport. Mol Biol Cell 2006; 17: 163-77.
26. Roberts M, Barry S, Woods A, van der Sluijs P, Norman J,. PDGF-regulated rab4-dependent recycling of alpha v beta 3 integrin from early endosomes is necessary for cell adhesion and spreading. Curr Biol 2001; 11: 1392-402.
27. Alguacil J, Pfeiffer RM, Moore LE, Del Fresno MR, Medina-Lopez R, Kogevinas M, Vermeulen R, Dosemeci M, Silverman DT, Rothman N, Garcia-Closas M,. Measurement of urine pH for epidemiological studies on bladder cancer. Eur J Epidemiol 2007; 22: 91-8.
28. Shi F, Sottile J,. Caveolin-1-dependent beta1 integrin endocytosis is a critical regulator of fibronectin turnover. J Cell Sci 2008; 121: 2360-71.
29. Lobert VH, Brech A, Pedersen NM, Wesche J, Oppelt A, Malerod L, Stenmark H,. Ubiquitination of alpha 5 beta 1 integrin controls fibroblast migration through lysosomal degradation of fibronectin-integrin complexes. Dev Cell 19: 148-59.
30. Khandelwal P, Ruiz WG, Apodaca G,. Compensatory endocytosis in bladder umbrella cells occurs through an integrin-regulated and RhoA- and dynamin-dependent pathway. EMBO J 29: 1961-75.